Notes

1Ostrove, S.: Qualification and Change Control. In: Validation of Pharmaceutical Processes, 3rd Ed; Editors: Agalloco, J., Carlton, F. New York: Informa Healthcare USA, Inc., 2008, Chapter 9, pp. 129–145.


2Title 21 CFR Part 211 Subpart D, FDA, 2015.


3Process Validation A Life Cycle Approach; Grace McNally; FDA May 2011 slide presentation on www.FDA.gov


4Guidance for Industry Process Validation: General Principles and Practices, FDA, Jan. 2011.


5Stand alone system—several components working as a single unit of operation (eg, a pump and a tank).


6Note: This is often combined with part of the process performance qualification and may become a part of the validation teams’ efforts (whereas the IQ and OQ testing are often performed by the engineering group).


7Guidance for Industry: PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance, FDA, Sep. 2004.


8Bringert, G.: Calibration and Metrology, In: Validation of Pharmaceutical Processes, 3rd Ed; Editors: Agalloco, J., Carlton, F. New York: Informa Healthcare USA, Inc., 2008, Chapter 7, pp. 99–108.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 4, 2017 | Posted by in PHARMACY | Comments Off on Notes

Full access? Get Clinical Tree

Get Clinical Tree app for offline access